Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Cash from Operations (2022 - 2023)

Historic Cash from Operations for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$4.7 million.

  • Mainz Biomed's Cash from Operations rose 121.3% to -$4.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$21.9 million, marking a year-over-year decrease of 4854.07%. This contributed to the annual value of -$17.1 million for FY2024, which is 2210.16% up from last year.
  • Latest data reveals that Mainz Biomed reported Cash from Operations of -$4.7 million as of Q4 2023, which was up 121.3% from -$6.5 million recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed's Cash from Operations peaked at -$2.8 million during Q1 2022, and registered a low of -$6.5 million during Q3 2023.